Categories AlphaGraphs, Earnings, Technology

CRWD Earnings: A snapshot of CrowdStrike’s Q4 2023 report

Cybersecurity company CrowdStrike Holdings, Inc. (NASDAQ: CRWD) reported higher adjusted earnings and revenues for the fourth quarter of 2023.

Fourth-quarter net income, excluding special items, rose to $0.47 per share from $0.30 per share a year earlier. On an unadjusted basis, it was a net loss of $47.5 million or $0.20 per share, compared to a loss of $41.9 million or $0.18 per share in the fourth quarter of 2022.

The positive earnings performance, on an adjusted basis, reflects a 48% increase in fourth-quarter revenues to $637.4 million, with strong contributions from the core Subscription division.


Check this space to read management/analysts’ comments on quarterly reports


CrowdStrike’s chief financial officer Burt Podbere said, “CrowdStrike delivered an exceptional fourth quarter and strong finish to the year. We remain focused on delivering increased operating leverage while continuing our thoughtful, disciplined and strategic approach to investing in innovation and market share expansion to capture the massive opportunities we see ahead for CrowdStrike.”

_________________________________________________________________________________________________________________

Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock

_________________________________________________________________________________________________________________

Most Popular

Citigroup set to report Q4 2025 earnings. Here’s what to expect

Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the

Home Depot (HD), Lowe’s (LOW): Home improvement pressures not expected to abate soon

Home improvement retailers Home Depot (NYSE: HD) and Lowe’s Companies, Inc. (NYSE: LOW) have been facing a challenging operating environment for a while now. The companies have been battling macroeconomic

Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8%

Medical technology company AngioDynamics, Inc. (NASDAQ: ANGO) on Tuesday reported an increase in net sales for the second quarter of fiscal 2026. In Q2, net sales increased 8.8% year-over-year to

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top